Lung Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People diagnosed with stage IV or returning (recurrent) non-small cell lung cancer who either have saved tumour tissue available for genetic testing, or are willing to have a new biopsy taken for this purpose — including those whose tumour has already been genetically tested.
- People with a general health/activity level rated 0, 1, or 2 on the Zubrod scale, which measures how much a person's illness affects their daily activities (confirm with trial site).
- People with a life expectancy of at least 3 months.
- People whose blood test results show healthy enough levels of white blood cells (neutrophils), platelets, and kidney and liver function — specific thresholds apply and will be checked by the trial team.
- People whose blood tests were done within 30 days before joining the trial.
- People who have a tumour biopsy sample available for genetic analysis — if using a previously collected sample, it must have been taken within 60 days of joining, the person must not have received any cancer treatment since that biopsy was taken, and the sample must not come from a part of the tumour that received radiation treatment.
- People who have read and signed a consent form explaining that this is a research study.
Who may not be able to join:
- People with another active cancer at the same time, unless the treating doctor considers it unlikely to affect the person's outcome in this trial.
- People with serious medical conditions, including uncontrolled heart failure, uncontrolled chest pain (angina), a heart attack or stroke within the past 6 months, a history of chronic active hepatitis, a history of HIV, or a currently active bacterial infection.
- Women who are pregnant or breastfeeding — women of childbearing age will be informed that if they join a treatment trial based on their genetic results, pregnancy may affect their ability to participate, and all sexually active participants joining a treatment trial will be required to use contraception.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Gerold Bepler, M.D., Barbara Ann Karmanos Cancer Institute
Phone: (313) 576-8665
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Proportion of patients receiving therapy based on genomic analyses among all eligible patients
Can't join this trial?
Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.